C. Papadimitriou

The complexity of immunohistochemical staining pattern of hodgkin and sternberg‐reed cells—demonstration of immunoglobulin, albumin, α₁‐antichymotrypsin and lysozyme

C. Papadimitriou, Harald Stein, K. Lennert · International Journal of Cancer · 1978 · 102 citations

Medicine, Hematology, Pathology +16

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Dimosthenis Skarlos, Urania Dafni et al. · Annals of Oncology · 2005 · 100 citations · Full text

Medicine, Oncology, Pharmacology +12

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer

George Fountzilas, Urania Dafni, Meletios Α. Dimopoulos et al. · Breast Cancer Research and Treatment · 2008 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial

P. Kosmidis, N. Mylonakis, Dimosthenis Skarlos et al. · Annals of Oncology · 2000 · 74 citations · Full text

Medicine, Oncology, Pharmacology +12

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Haralabos P. Kalofonos, Urania Dafni et al. · Annals of Oncology · 2004 · 69 citations · Full text

Medicine, Oncology, Pharmacology +9